Antiglaucomatous Effects of the Activation of Intrinsic Angiotensin-Converting Enzyme 2
Author(s) -
Giselle Foureaux,
José Carlos Nogueira,
B. S. Nogueira,
Gustavo O. Fulgêncio,
Gustavo Batista Menezes,
Simone Odília Antunes Fernandes,
Valbert Nascimento Cardoso,
Renata Salgado Fernandes,
Gabriel P. Oliveira,
Juçara Ribeiro Franca,
André Augusto Gomes Faraco,
Mohan K. Raizada,
Anderson José Ferreira
Publication year - 2013
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.12-11427
Subject(s) - angiotensin converting enzyme 2 , glaucoma , chemistry , renin–angiotensin system , pharmacology , medicine , endocrinology , blood pressure , ophthalmology , disease , covid-19 , infectious disease (medical specialty)
To evaluate the effects of the activation of endogenous angiotensin-converting enzyme 2 (ACE2) using the compound diminazene aceturate (DIZE) in an experimental model of glaucoma in Wistar rats.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom